Levin Capital Strategies, L.P. Aura Biosciences, Inc. Transaction History
Levin Capital Strategies, L.P.
- $901 Million
- Q1 2025
A detailed history of Levin Capital Strategies, L.P. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 1,360,768 shares of AURA stock, worth $9.21 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
1,360,768
Previous 1,247,619
9.07%
Holding current value
$9.21 Million
Previous $10.3 Million
22.24%
% of portfolio
0.88%
Previous 1.02%
Shares
9 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
40.3MCall Options Held
6KPut Options Held
6.4K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$46.9 Million12.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$33 Million0.06% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR3.32MShares$22.5 Million0.67% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$20.6 Million5.39% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$20.3 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $198M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...